management of the cardiac and respiratory support. 2 Thus, an optimal monitoring equipment should provide information regarding the pump function as revolution per minute (r/min), blood flow (BF) (l/min), inlet and outlet pressures (mmHg) and the membrane lung (ML) performance. 3 Evaluation of the ML performance is of paramount importance during ECMO, not only because it might indicate a gradual or sudden functional impairment and therefore the need and timing for ML replacement due to clot formation inside the oxygenator, but may also provide information regarding both the native lung (NL) and the ML contribution to the global ventilation, hence guiding the weaning process. 4 Furthermore, as for NL, ML performance is assessed by measuring both O 2 transfer through the ML (V′O 2 ML) and CO 2 removal (V′CO 2 ML) through the oxygenator.
While some devices applied to the ECMO circuits already allow for continuous monitoring of V′O2ML, there are only two systems currently available for continuous monitoring of V′CO 2 ML. However, the continuous evaluation of CO 2 removal by ML (V′CO 2 ML) is extremely important, since it also allows the ML dead space calculation (VDsML), which can be altered due to clot formation inside the oxygenator and fibres oedema (as the plasma leakage phenomenon). In this situation, fractions of the ML are ventilated but not perfused, hence, they do not participate in the CO 2 removal. Moreover, a continuous measurement of the CO 2 removed by the oxygenator allows a more precise distinction between the different contributions of both the patient and the oxygenator to the global ventilation and, hence, provides significant information during weaning from the ECMO machine. Moreover, a continuous monitoring of CO 2 percentage in the exhaust gas could be used as an alarm for gas flow failure or disconnection.
In our experimental study, we tested the accuracy and reliability of a new volumetric capnometer which enables continuous monitoring of V′CO 2 ML by direct measurement of the CO 2 partial pressure at the exhaust gas port of the ML (%) and the gas flow (l/min), and to calculate the dead space during ECMO.
Methods
The current animal model experiment was conducted at the University Hospital of Maastricht, The Netherlands, on nine pigs undergoing veno-arterial ECMO (VA ECMO). The protocol was approved by the ethical committee of the University Hospital of Maastricht (protocol number WP 2015-003-001).
The pigs were anaesthetized, intubated and ventilated by constant ventilator settings. This study was conducted as part of a major study aimed at comparing the effects of treatments alone with VA ECMO in addition to intra-aortic balloon pump (IABP) in pigs in cardiogenic shock. Such a condition was obtained by inducing an acute myocardial infarction (left anterior descending coronary artery ligature) and, after 4 hours of monitoring, the two capnometers were tested. The tubing set and the ECMO oxygenators (model 'adult ECMO 14 days') were provided by Eurosets srl, Medolla, Italy.
In more details, we evaluated the accuracy and reliability of the prototype of a new volumetric capnometer device (CO 2 RESET ™ , Eurosets srl, Medolla, Italy) that provides directly and continuously the V′CO 2 ML values and the VDsML calculation, by comparing the obtained measurements with the new device with those obtained with a control standard method.
As a control device, we used a capnometer (Microcap Plus ® Capnograph, Medtronic, Minneapolis, Minnesota, USA) which is routinely used in clinics for measurements of the CO 2 concentration in the exhaled air of the patient (the end-tidal CO 2 , expressed as %) and the values of gas flow displayed on the standard gas blender.
We measured V′CO 2 ML and VDsML at five different levels of gas flow/BF ratio, (0.5-1.5) and we obtained three V′CO 2 ML measurements for each level of gas flow/BF ratio (in total, 135 couples of values expected), while only one for the VDsML at each level of gas flow/ BF (in total, 45 couples of values expected). We performed a blood gas analysis at each level of gas flow/BF to obtain the CO 2 blood partial pressure in the inlet blood from oxygenator (pCO 2 ) and the CO 2 blood partial pressure in the outlet blood from oxygenator (pCO 2 ) Moreover, we also continuously recorded both pig body and pig exhaust gas temperatures.
Device characteristics
The new device consists of a mid-range infrared sensor placed mainstream (compared with the control device with side-stream sampling) to the oxygenator exhaust connector, combined with a flow sensor device placed at the oxygenator gas inlet ( Figure 1 ). The CO 2 concentration is calculated on the basis of the radiation variation caused by the CO 2 absorption characteristics, as with the common capnometers. However, not only does the combination of the capnometer and flowmeter allow continuous evaluation of the percentage of CO 2 exhaust by the ML, but also the continuous V′CO 2 ML calculation. Furthermore, a system placed inside the capnometer maintains the temperature of the gas exhaust between 40 and 42°C, avoiding condensation as well as misleading measurements. Ultimately, a dedicated software tool calculates the measurements and shows CO 2 [%], CO 2 [mmHg], inlet gas flow [l/min] and V′CO 2 ML [ml/min].
The control capnometer is a clinically validated device for measuring the CO 2 concentration in patient exhaled gases. It works with an internal sensor (based on radiation absorption technology) by sampling the gases from the exhaust gas port of the oxygenator through a narrow tube. It is possible to calculate intermittently the V′CO 2 ML combined CO 2 percentage obtained by the hand-held standard capnometer with the contemporary value of sweep gas set on the gas blender.
V′CO 2 ML and dead space monitoring
While the concentration (%) of carbon dioxide in exhaust gas (%CO 2 ) from the ML and V′CO 2 ML was directly shown on the screen by 'CO 2 RESET' capnometer's software, the value of V′CO 2 ML derived from the measured %CO 2 with the second method was calculated as follows
where GF is the gas flow, %CO 2 is the concentration as percentage of CO 2 in exhaust gas and V′CO 2 ML is the ML carbon dioxide removal. In addition, the two methods were compared for the dead space calculation, which was obtained by the following equation
where VDsML is the ML dead space, pCO 2 out is the carbon dioxide partial pressure into the outlet blood and %CO 2 is the concentration of carbon dioxide in the gas sampled at the exhaust gases port of the oxygenator.
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics for Windows, Version 24, IBM Corporation 2015, Armonk, NY, USA.
The correlations between all the obtained measurements with the new volumetric capnometer and those obtained with the control method (Microcap Plus Capnograph, Medtronic, Minneapolis, Minnesota, USA) were calculated using the Spearman's correlation coefficient. A level of p < 0.05 was chosen to indicate the statistical significance.
The Bland-Altman 5 method was used to evaluate the agreement between the measurement taken with the control and new methods, after assessing the normal distribution of the differences. The lack of agreement was summarized by calculating the bias, estimated by the mean difference (d) and the standard deviation of the differences (s). We expected that 95% of differences were between d-1.96s and d + 1.96s.
Results
We obtained 120 coupled measurements for each method suitable for the V′CO 2 ML calculation and 40 coupled measurements suitable for the VDsML calculation. Because of a failure in the capnometer's heater system, the data recorded by one animal was judged potentially not reliable and was not included.
As seen in Figure 2 (a) and (b), we observed a strong correlation between the measurements of V′CO 2 ML, (r s = 0.991; p = 0.0005) taken with the volumetric capnometer, and those obtained with the control method. Moreover, the volumetric capnometer showed a low mean percentage bias for V′CO 2 ML measurements at exactly 3.86% (12.07-4.35%).
Regarding the dead space calculation, not only did we observe a significant correlation between the two methods for VDsML calculation (r s = 0.973; p = 0.0005), but we also identified a very low mean percentage bias with the volumetric capnometer at 2.62% (8.96-14.20%), as can be seen in Figure 3(a) and (b) .
In addition, although a negative proportional bias for V′CO 2 ML estimation with the volumetric capnometer was observed, such underestimation in the lower range of V′CO 2 ML was less than 4%, which represents an acceptable limit for the clinical setting.
Moreover, we investigated whether variations in gas temperature and gas flow/BF ratio could have affected the differences in the coupled measurements obtained with the two devices. In this regard, we found no significant correlations between the difference in the coupled V′CO 2 ML and VDsML measurements for either the gas flow/BF ratio or temperature.
Finally, Figure 4 shows the variation of VDsML at increasing gas flow/BF ratios. As it can be observed, increasing gas flow/BF ratios (increased ventilation per unit of blood) correspond to higher values of VDsML. This can be explained by the fact that the increase in the ventilation per unit of blood implies a corresponding increase in the ventilation per mm 2 of oxygenator's membrane up to a certain threshold, which is determined by the permeability properties of the membrane. Once the threshold has been reached, a further increase in ventilation will create an increase in dead space (in series).
Discussion
In this study, we evaluated the accuracy and reliability of a new volumetric capnometer which allows the continuous V′CO 2 ML monitoring and VDsML calculation, thanks to its two components. The flowmeter was placed in series to the sweep gas line, and the capnometer was positioned at the exhaust gas port of the oxygenator. ECMO constitutes a life-saving mechanical support which often requires accurate monitoring and potentially prompt interventions because of either variation in patient clinical conditions, the occurrence of possible complications, or ECMO system malfunction. Thus, an appropriate and continuous monitoring of gas exchange inside the oxygenator is useful in order to evaluate both the ML performance and to distinguish between the ML and NL ventilation. 2 Currently, data regarding ML gas exchange are usually obtained by taking blood samples by the ECMO circuit added to the volumetric capnometry of the ML during the routine ECMO check at least daily. However, due to the complexity of the support machine, of the patient-machine interactions, together with the high risk of system-related complications during prolonged use, there could be great benefit by the use of an online monitoring system, which can provide real-time information regarding both the ML and the pump performances. In fact, the study of the trend in the V′CO 2 ML permits to avoid bias related to the specific moment in which the single measurement has been taken, constituting a more realiable tool. Hence, we believe that the continuous monitoring of both CO 2 removal and ML dead space with the volumetric capnometer allows better timing for the detection of ML dysfunction and can potentally guide the ECMO weaning process by integrating ML and mechanical ventilator information.
In addition, with regard to the patient complications related to ECMO use, it is reported that ML failure constitutes the second most common mechanical complication. 6 Moreover, despite the advent of new ML coated with a tip-to-tip antithrombotic surface coating, the interactions of blood with non-biological surfaces boost the systemic inflammatory response and lead to clotting within the ML. 7 Such deposits are responsible for the worsening of ML gas exchanges because of an increased dead space inside the oxygenator and, hence, of an increased proportion of ventilated but not perfused areas. Therefore, we believe that continuous evaluation of the V′CO 2 ML other than the dead space can not only highlight an ML performance reduction, but also guide the ML replacement timing. For instance, provided that ML replacement does not constitute a no-risk procedure in those patients, the V′CO 2 ML evaluation could allow a monitored delay in its replacement, whenever the CO 2 clearance is sufficient for the patient's clinical needs.
In addition, discontinuing extracorporeal respiratory support is another crucial step in ECMO patient management, and it often constitutes a difficult decision, mainly due to the lack of definite criteria. Mols et al. 8 indicated the successful weaning from the ECMO machine when at least 80% of total oxygen delivery was supplied by the patient's own lung. 8 Similarly, Grasselli et al. 9 suggested that the respiratory mechanics and patient blood gases should also be considered in the decision of ECMO withdrawal. On the other hand, we previously reported how the combined evaluation of CO 2 removal through the ML (V′CO 2 ML) and CO 2 removal through the NL (VCO 2 NL) obtained by the volumetric capnometry function integrated in the modern ventilators could provide additional information regarding NL recovery such as improvements in its CO 2 These data show that the increase in gas BF/GF ratios corresponds to an increase in the VDsML values, as a consequence of the overcome capacity of the ML membrane in terms of CO 2 elimination.
clearance capability. 10 In our opinion, in fact, in order to estimate the residual function of the NL more accurately, clinicians should analyse not only the oxygenation function (V′O 2 ML) of the ML, but also the extracorporeal CO 2 removal (V′CO 2 ML). Thus, the continuous V′CO 2 ML monitoring by the new volumetric capnometer could potentially help in analysing NL/ML interaction, guiding the ECMO weaning process and choosing the best timing for the ECMO discontinuation. 3 
Limitation of the study
Since there is still no standard method of measuring CO 2 in the exhaust of the oxygenator, calculating CO 2 removal would be appropriate by taking blood gases before and after the ML compared with exhaust blood gas analysis. Therefore, future evaluation should address the comparison between pre/post-ML blood and exhausted gas analysis to conclusively validate the new method, hoping that a low difference within a clinically acceptable range will be detected.
Conclusion
In conclusion, our experimental study demonstrates that the volumetric capnometer used in conjunction with the ECMO oxygenator is reliable for continuous monitoring of V′CO 2 and useful for oxygenator dead space calculation, as the measurements obtained with a control method by a normal capnometer. Moreover, we believe that the information provided by such a device is helpful to promptly detect oxygenator malfunction and its impaired performance in terms of CO 2 removal. Furthermore, if these monitoring approaches are confirmed in future studies, the V′CO 2 ML continuous monitoring could help to better guide ECMO weaning and improve the patient management. Further studies are vital in order to confirm our results in a clinical setting.
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